Taysha Gene Therapies, Inc. (TSHA) - Company Total Revenue

Symbol and logo of brand Taysha Gene Therapies Inc (TSHA)

The overall sales level of Taysha Gene Therapies (TSHA) reflects demand dynamics, where the value remains at 0.01. Taysha Gene Therapies (TSHA) focuses on treating rare CNS pathologies, including Rett syndrome. Growth is driven by the accelerated rollout of breakthrough drugs for monogenic disorders. Intellectual property protection and orphan status create significant barriers for competitors in the gene therapy sector.

Taysha Gene Therapies, Inc. - TSHA Revenue and Sales Volume (period 07/04/2022 - 11/18/2026)

Analytical breakdowns for Taysha Gene Therapies, Inc. (TSHA)

- market capitalization indicators:
Summary company analysis:Taysha Gene Therapies - TSHA
Flagship merchandise of tayshagtx.com

Taysha Gene Therapies (TSHA) sales reflect actual daily revenue, allowing for an assessment of the issuer's resilience to inflationary shocks and interest rate changes. By analyzing the company's sales volume history, an investor can track the dynamics of cash inflows from product sales. This metric aggregates all operating income for the reporting period to determine market share. For Taysha Gene Therapies (TSHA), this figure remains minimal, as CNS gene therapy is currently in the clinical testing stage. Growth in this indicator is expected only after the commercialization of the drugs.

Key competitors

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue uniQure Corp|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales